Abstract

The present study was designed to investigate the hypolipidemic effect of ethanolic extract from whole plant of Lactuca runcinata (DC.) in rats fed with atherogenic diet (AD). The acute toxicity study shows that the ethanolic extract are safe up to 2000 mg/kg, thus one tenth of this dose was consider as evaluation dose. Ethanolic extract of Lactuca runcinata was administered in doses of 200 and 400 mg/kg/day to rats fed with atherogenic diet to assess its possible lipid-lowering potential. There was a recognize increment in the body weight in AD fed group (p<0.001), which was reduced by the administration of ethanolic extract of L. runcinata (400 mg/kg). The elevated levels of total cholesterol, triglycerides, phospholipids, low-density lipoprotein (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) all along with decrease in plasma HDL-C were observed in group II rats fed with atherogenic diet. After treatment of ethanolic extract of L. runcinata, (400 mg/kg/day) the result showed a significant (p<0.001) decrement in body weight, plasma and tissue total cholesterol, triglycerides, phospholipids, plasma LDL-C and VLDL-C although with an increase in plasma HDL-C when compared to group II AD rats. The ethanolic extract of L. runcinata could protect against atherosclerosis and decrease the atherogenic index and cardiac risk ratio. This finding provides some biochemical basis for the use of ethanolic extract of whole plant of L. runcinata as hypolipidemic agent having preventive and therapeutic effect against hyperlipidemia.   Key words: Atherogenic diet, hypolipidemia, Lactuca runcinata, wistar rats.

Highlights

  • Hyperlipidemia is a known risk factor for the advancement of cardiovascular diseases including atherosclerosis

  • The present study was designed to investigate the hypolipidemic effect of ethanolic extract from whole plant of Lactuca runcinata (DC.) in rats fed with atherogenic diet (AD)

  • The elevated levels of total cholesterol, triglycerides, phospholipids, low-density lipoprotein (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) all along with decrease in plasma HDL-C were observed in group increased in AD group (II) rats fed with atherogenic diet

Read more

Summary

Introduction

Hyperlipidemia is a known risk factor for the advancement of cardiovascular diseases including atherosclerosis. The real risk components for the advancement of atherosclerosis are hypercholesterolemia and raised levels of low-density lipoprotein cholesterol (LDL-C). Free-radical-mediated peroxidative modification of polyunsaturated fatty acids of LDL and very lowdensity lipoprotein (VLDL) is thought to add to the development of atherosclerotic injuries. Oxidative anxiety is an early occasion in the advancement of hyperlipidemia, and it has been proposed that proper support for improving antioxidant supply in subjects with anomalous elevated lipid levels can lessen the course of the disease (Yang et al, 2008). Clinical trials have demonstrated that treatment of more seasoned high-risk subjects with lipid-lowering medications can lessen cardiovascular grimness and mortality (Aronow, 2008). The investigation for new agents fit for diminishing serum lipid levels has thusly turn into a vital examination center

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call